However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
House Republicans reported “very positive developments” after a marathon meeting at the White House on Thursday focused on ...
Wells Fargo analyst Eva Fortea Verdejo initiated coverage of Merus (MRUS) with an Overweight rating and $91 price target The firm thinks ...
How Tech Billionaires on the Right Bought the Loudest Voices on the Left," discusses how tech billionaires changed the media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results